m+Medelevator.RU
← Поиск публикаций
MedComm · 2026

Network Biology: Current Status, Applications, Challenges, and Future Prospects.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Li Xinmeng, Zhang Laizhong, Ding Yawen, Li Kai, Chang Shiyuan, Pei Linsen, Li Zhengwei, Chen Zhenzhen

Аннотация

Network biology provides a systems-level framework for understanding how interactions among molecular components, cells, microbial communities, tissues, and organs generate biological function and disease phenotypes. Recent advances in multiomics, single-cell and spatial profiling, network inference, organoid and organ-on-chip technologies, computational modeling, and artificial intelligence have shifted the field from static molecular maps toward dynamic, multiscale, and predictive network models. Major branches include molecular interaction networks, intracellular regulatory networks, single-cell and multicellular networks, microbial networks, disease networks, and interorgan interaction networks. Experimental and computational approaches are compared with respect to network reconstruction, causal validation, and cross-scale integration. Biomedical applications span disease classification, biomarker discovery, therapeutic-target identification, drug-response prediction, regenerative medicine, and precision healthcare. Particular emphasis is placed on interorgan interaction networks, in which carrier, route, range, timescale, recipient specificity, directionality, and feedback are treated as distinct mechanistic dimensions while mechanistic confidence is distinguished from translational maturity. Persistent challenges include incomplete context-specific network reconstruction, uncertain causal directionality, limited cross-scale integration, model interpretability, and insufficient clinical validation. Further progress will depend on integrating longitudinal and perturbation-resolved measurements with human-relevant experimental systems and multiscale computational models that quantify uncertainty and support prospective validation of patient-specific predictions.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты